Hydration protocol Dehydration is the silent saboteur of GLP-1 therapy
Foundayo (Orforglipron) The newest addition, Foundayo, approved in 2026, continues the innovation in weight loss medications with a daily, flexible dosing schedule
When designing semaglutide, a realistic concern was if it would be possible to stabilize a GLP-1 analog against systemic clearance to achieve plasma levels sufficient to control blood glucose following OW dosing
Prefilled pens may allow for slightly longer storage because the sealed delivery mechanism reduces air exposure compared to multi-dose vials
Over 68 weeks, the participants saw an average weight reduction of 15.8% with semaglutide, compared to 6.4% with liraglutide
By using Semaglutide GLP-1 to regulate appetite and improve insulin response, Watson creates a foundation for steady fat reduction and improved metabolic health without extreme dieting